Momenta Pharmaceuticals, Inc. - MNTA - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Momenta Pharmaceuticals, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
MNTA	Nasdaq	8731	http://www.momentapharma.com/	14.12 -0.29
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Momenta Pharmaceuticals, Inc. Coverage initiated on Momenta Pharma by WallachBeth - Jun 17th, 2013 9:45 pm White Collar Criminals Love Biotech Stocks - Jun 16th, 2013 5:00 pm Why the Pfizer-Teva Settlement Affects the Whole Industy - Jun 13th, 2013 11:53 am MOMENTA PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statem - Jun 13th, 2013 1:16 am Commit To Buy Momenta Pharmaceuticals At $11, Earn 15.7% Annualized - Jun 10th, 2013 12:29 pm Movers roundup: Ascena Retail, Momenta - Jun 6th, 2013 4:04 pm Movers roundup: Ascena Retail, Momenta - Jun 6th, 2013 4:04 pm Momenta Pharma rises following upgrade from UBS - Jun 6th, 2013 2:44 pm Momenta Pharma rises following upgrade from UBS - Jun 6th, 2013 2:44 pm Stock Upgrades: Stick to Henkel Like Glue - Jun 6th, 2013 7:18 am Why Baxter Is Soaring Despite Alzheimer's Disappointment - May 29th, 2013 3:31 pm Momenta Pharmaceuticals' Management Presents at 38th Annual dbAccess Health Care Conference (Transcript) - May 29th, 2013 3:17 pm The 5 Best Dividend Stocks of 2020 - May 26th, 2013 1:45 pm Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences - May 23rd, 2013 2:30 pm Momenta Pharmaceuticals Management Presents at 2013 UBS Global Healthcare Conference (Transcript) - May 22nd, 2013 12:09 pm Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry - May 22nd, 2013 10:56 am MOMENTA PHARMACEUTICALS INC Financials - May 17th, 2013 11:04 am Momenta Pharmaceuticals Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) - May 15th, 2013 10:17 pm Momenta Pharmaceuticals (MNTA) Shares Cross Above 200 DMA - May 13th, 2013 2:36 pm MOMENTA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report - May 10th, 2013 3:03 am View All Current Headlines >>